Penumbra, Inc (PEN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
74/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 9 wins, 3 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LosePEN / S&P -3.84% / 15.20% |
WinPEN / S&P 17.55% / 15.00% |
LosePEN / S&P 7.96% / 50.40% |
| 2026-Q13/3 |
WinPEN / S&P 5.62% / -4.33% |
WinPEN / S&P 17.27% / 11.30% |
WinPEN / S&P 305.61% / 27.70% |
| 2025-Q43/3 |
WinPEN / S&P 22.73% / 2.65% |
WinPEN / S&P 17.50% / 9.00% |
WinPEN / S&P 1191.43% / 13.40% |
| 2025-Q32/3 |
LosePEN / S&P -1.29% / 8.12% |
WinPEN / S&P 14.61% / 4.61% |
WinPEN / S&P 387.21% / 13.45% |
| 2025-Q22/3 |
LosePEN / S&P -4.03% / 10.94% |
WinPEN / S&P 12.92% / 4.83% |
WinPEN / S&P 1008.82% / 10.63% |
| 2025-Q12/3 |
WinPEN / S&P 12.60% / -4.27% |
WinPEN / S&P 13.17% / 4.98% |
LosePEN / S&P -54.85% / 10.57% |
| 2024-Q42/3 |
WinPEN / S&P 22.22% / 2.41% |
WinPEN / S&P 12.86% / 5.25% |
LosePEN / S&P -84.85% / 6.15% |
| 2024-Q32/3 |
WinPEN / S&P 7.97% / 5.89% |
WinPEN / S&P 16.96% / 5.89% |
LosePEN / S&P -17.31% / 6.11% |
| 2024-Q21/3 |
LosePEN / S&P -19.36% / 4.28% |
WinPEN / S&P 20.89% / 5.38% |
LosePEN / S&P -54.67% / 5.12% |
| 2024-Q12/3 |
LosePEN / S&P -11.27% / 10.56% |
WinPEN / S&P 23.87% / 5.71% |
WinPEN / S&P 1294.12% / 5.59% |
| 2023-Q41/3 |
LosePEN / S&P 3.98% / 11.69% |
WinPEN / S&P 24.95% / 6.81% |
LosePEN / S&P -4720.00% / 7.78% |
| 2023-Q31/3 |
LosePEN / S&P -29.69% / -3.27% |
WinPEN / S&P 19.90% / 7.52% |
LosePEN / S&P -226.83% / -5.03% |
| 2023-Q22/3 |
WinPEN / S&P 23.46% / 8.74% |
WinPEN / S&P 16.30% / 9.50% |
LosePEN / S&P -244.23% / -8.57% |
| 2023-Q12/3 |
WinPEN / S&P 25.28% / 7.50% |
WinPEN / S&P 13.08% / 10.77% |
LosePEN / S&P -200.00% / -15.69% |
| 2022-Q42/3 |
WinPEN / S&P 17.33% / 7.56% |
WinPEN / S&P 13.32% / 11.88% |
LosePEN / S&P -133.33% / -17.99% |
| 2022-Q32/3 |
WinPEN / S&P 52.26% / -4.88% |
WinPEN / S&P 16.81% / 13.47% |
LosePEN / S&P -190.11% / -1.41% |
| 2022-Q21/3 |
LosePEN / S&P -43.94% / -16.10% |
WinPEN / S&P 20.10% / 13.71% |
LosePEN / S&P -220.93% / 11.04% |
| 2022-Q11/3 |
LosePEN / S&P -22.69% / -4.60% |
WinPEN / S&P 32.08% / 15.97% |
LosePEN / S&P 6.25% / 42.23% |
| 2021-Q41/3 |
LosePEN / S&P 7.81% / 11.03% |
WinPEN / S&P 33.40% / 15.00% |
LosePEN / S&P -134.09% / 96.40% |
| 2021-Q31/3 |
LosePEN / S&P -2.76% / 0.58% |
WinPEN / S&P 31.87% / 10.77% |
LosePEN / S&P -437.04% / 69.42% |
| 2021-Q21/3 |
LosePEN / S&P 1.29% / 8.55% |
WinPEN / S&P 27.36% / 6.58% |
LosePEN / S&P 48.28% / 51.81% |
| 2021-Q12/3 |
WinPEN / S&P 54.62% / 6.17% |
WinPEN / S&P 6.47% / -1.06% |
LosePEN / S&P -114.68% / 7.39% |
| 2020-Q41/3 |
LosePEN / S&P -9.97% / 12.15% |
WinPEN / S&P 2.38% / -3.72% |
LosePEN / S&P -132.59% / -33.42% |
| 2020-Q31/3 |
LosePEN / S&P 8.70% / 8.93% |
WinPEN / S&P 3.03% / -2.04% |
LosePEN / S&P -121.43% / -27.10% |
| 2020-Q22/3 |
LosePEN / S&P 10.84% / 20.54% |
WinPEN / S&P 6.45% / -0.46% |
WinPEN / S&P -25.64% / -27.11% |
| 2020-Q13/3 |
WinPEN / S&P -1.79% / -19.60% |
WinPEN / S&P 18.19% / 3.47% |
WinPEN / S&P 263.33% / -14.75% |
| 2019-Q43/3 |
WinPEN / S&P 22.14% / 9.07% |
WinPEN / S&P 23.03% / 5.36% |
WinPEN / S&P 800.00% / 2.99% |
| 2019-Q32/3 |
LosePEN / S&P -15.94% / 1.70% |
WinPEN / S&P 24.45% / 5.02% |
WinPEN / S&P 425.00% / 0.21% |
| 2019-Q22/3 |
WinPEN / S&P 8.84% / 4.30% |
WinPEN / S&P 26.24% / 6.64% |
LosePEN / S&P -51.25% / 8.65% |
| 2019-Q12/3 |
WinPEN / S&P 20.30% / 13.65% |
WinPEN / S&P 29.57% / 8.12% |
LosePEN / S&P -21.05% / 14.29% |
| 2018-Q41/3 |
LosePEN / S&P -18.37% / -13.52% |
WinPEN / S&P 33.31% / 9.05% |
LosePEN / S&P 15.38% / 18.23% |
| 2018-Q32/3 |
WinPEN / S&P 8.36% / 7.71% |
WinPEN / S&P 35.19% / 10.21% |
LosePEN / S&P -209.09% / 19.06% |
| 2018-Q23/3 |
WinPEN / S&P 19.46% / 3.43% |
WinPEN / S&P 33.39% / 9.03% |
WinPEN / S&P 566.67% / 14.46% |
| 2018-Q13/3 |
WinPEN / S&P 22.90% / -0.76% |
WinPEN / S&P 30.38% / 7.68% |
WinPEN / S&P 46.15% / 12.46% |
| 2017-Q41/3 |
LosePEN / S&P 4.21% / 6.64% |
WinPEN / S&P 26.75% / 7.03% |
LosePEN / S&P -69.77% / 13.82% |
| 2017-Q31/3 |
LosePEN / S&P 2.91% / 4.48% |
WinPEN / S&P 27.06% / 5.68% |
LosePEN / S&P -138.60% / 17.57% |
| 2017-Q22/3 |
WinPEN / S&P 5.15% / 3.09% |
WinPEN / S&P 29.07% / 4.83% |
LosePEN / S&P -52.00% / 17.74% |
| 2017-Q13/3 |
WinPEN / S&P 30.80% / 6.07% |
WinPEN / S&P 35.87% / 3.67% |
WinPEN / S&P 420.00% / 13.32% |
| 2016-Q42/3 |
LosePEN / S&P -16.04% / 3.82% |
WinPEN / S&P 41.50% / 2.09% |
WinPEN / S&P 760.00% / 7.05% |
| 2016-Q33/3 |
WinPEN / S&P 27.71% / 3.85% |
WinPEN / S&P 46.41% / 0.20% |
WinPEN / S&P 5600.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 17.74% | 20.78% |
| Annualized return | 17.74% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 18.02% | 83.14% |
| Annualized return | 3.37% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | PEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 358.44% | 319.30% |
| Annualized return | 16.45% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |